Psychedelic Alpha provides independent data-driven reporting and analysis in the psychedelics space, including consultancy and advisory services for investors and entrepreneurs.

Psychedelic Alpha

Psychedelic Alpha | 6,745 followers on LinkedIn. Independent data-driven reporting, analysis and commentary on the psychedelics space. | The definitive resource for analysis of the emergent psychedelic medicine sector. Cut through the noise with exclusive news, interviews, data and opportunities.

Founder at Psychedelic Alpha - Commentary, Consultancy, Community for the psychedelics industry

Josh Hardman

Investigative Reporter | Psychedelic politics and public policy analysis from between the aisles and beyond.

Jack Gorsline

Patent Analyst at Calyx Law | JD Candidate at UCalgary Law (2027)

Noah Smith

Explore the topline results from the latest in our series of psychedelics investor surveys. https://lnkd.in/eWaiE8cT

Psychedelics on the Ballot 2024. Follow the latest from Massachusetts and Oregon, where voters are deciding on psychedelics-related measures. ∎ https://lnkd.in/gtGgNzAi

Pα+ Psychedelic Bulletin #179: VA Funds MDMA for PTSD and AUD Study, Chooses Low-Dose MDMA as Control; A Look at the Latest Oregon Psilocybin Services Complaints https://lnkd.in/ebYDmNUC

OP-Ed: From a Massachusetts Psychiatrist: Why Doctors Support Yes on Question 4 In this Opinions piece, Dr. Fernando Espi Forcen, a Massachusetts-based psychiatrist, medical director and assistant professor in psychiatry, responds to what he deems to be three of the most common misconceptions around Question 4. That question, if endorsed by voters next Tuesday, would decriminalise certain psychedelics and establish a state-regulated system of legal psychedelic services. https://lnkd.in/eys65PhR

Compass Pathways Pushes Back Phase 3 Readouts, Lays Off 30% of Staff https://lnkd.in/evSPMpyA

Pα+ Psychedelic Bulletin 178: VA Funding of Lykos Phase 3 ‘Definitely a Possibility’; Alto’s Precision Psychiatry Platform Under Pressure; MAPS Boosts Funding for Mass. Psychedelics Ballot Question https://lnkd.in/esTSDcQK

Natural Medicine Advisory Bulletin 14: Vicente LLP looks at big-picture questions as the program hurtles towards launch. First up are fees and rule changes, before the firm reviews Natural Medicine-related meetings since our last Bulletin in late August. https://lnkd.in/eTXjf9FR

Psychedelics Take Centre Stage in Massachusetts’ Local Media: Q4 Pros and Foes square off in ballot question debate series. https://lnkd.in/eznNeaPE

Next month, Massachusetts will vote on Question 4, which would establish a regulated psychedelics program in the state. Right now, it's too close to call with polls showing opinions are within the margin of error. What do you think will be the outcome?

Exclusive: David Hough on Lykos’ Path to Resubmission In this exclusive interview, our Editor Josh Hardman sat down with Hough to discuss how his experience in developing Spravato to eventual approval might inform any future clinical development of MDMA, Hough’s thoughts about the FDA’s verdict and the AdComm that preceded it, what a future Phase 3 program might look like, and more. https://lnkd.in/gSJEz6GU

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 22, 2024 7:50 AM	92ed783c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 22, 2024 7:50 AM	a547ab32
crunchbase trigger	general	Nov 22, 2024 7:50 AM	e4905a32
crunchbase profile	general
li profile	general	Nov 22, 2024 7:50 AM	45b5aec3
translate crunchbase fundingrounds	general
peers	general	Nov 22, 2024 7:50 AM	e334d0fd
news basic	general	Nov 22, 2024 7:50 AM	e795402b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PSYC

COM:PSYCHEDELICALPHA

Psychedelic Alpha